APO Research
Talk to an analyst

APO RESEARCH · REPORT

Women’s Health Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Women’s Health Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchWomen’s Health Diagnostics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Women’s Health Diagnostics Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Women’s Health Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Women’s Health Diagnostics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Women’s Health Diagnostics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Women’s Health Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Women’s Health Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Women’s Health Diagnostics include Siemens, Roche, Philips, Quest Diagnostics Inc., Perkinelmer Inc., Hologic, Inc., GE Healthcare, Biomerieux SA and Becton, Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Women’s Health Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Women’s Health Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Women’s Health Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Women’s Health Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

Women’s Health Diagnostics Segment by Company

Siemens

Roche

Philips

Quest Diagnostics Inc.

Perkinelmer Inc.

Hologic, Inc.

GE Healthcare

Biomerieux SA

Becton, Dickinson and Company

Alere Inc.

Abbott Laboratories

Women’s Health Diagnostics Segment by Type

Diagnostic Devices

Diagnostic Tests

Women’s Health Diagnostics Segment by Application

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Breast Cancer

Sexually Transmitted Disease Testing

Others

Women’s Health Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women’s Health Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Women’s Health Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women’s Health Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Women’s Health Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Women’s Health Diagnostics industry.

Chapter 3: Detailed analysis of Women’s Health Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Women’s Health Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Women’s Health Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Diagnostic Devices Table 3. Key Players of Diagnostic Tests Table 4. Global Women’s Health Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Infectious Disease Testing Table 6. Key Players of Osteoporosis Testing Table 7. Key Players of Pregnancy and Fertility Testing Table 8. Key Players of Breast Cancer Table 9. Key Players of Sexually Transmitted Disease Testing Table 10. Key Players of Others Table 11. Global Women’s Health Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Women’s Health Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Women’s Health Diagnostics Market Share by Region (2021-2026) Table 14. Global Women’s Health Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Women’s Health Diagnostics Market Share by Region (2027-2032) Table 16. Women’s Health Diagnostics Industry Trends Table 17. Women’s Health Diagnostics Industry Drivers Table 18. Women’s Health Diagnostics Industry Opportunities and Challenges Table 19. Women’s Health Diagnostics Industry Restraints Table 20. Global Women’s Health Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Women’s Health Diagnostics Revenue Market Share by Company (2021-2026) Table 22. Global Women’s Health Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Women’s Health Diagnostics Key Company Head Office and Area Served Table 24. Global Women’s Health Diagnostics Company, Product Type & Application Table 25. Global Women’s Health Diagnostics Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Women’s Health Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Women’s Health Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Women’s Health Diagnostics Revenue Market Share by Type (2021-2026) Table 32. Global Women’s Health Diagnostics Revenue Market Share by Type (2027-2032) Table 33. Global Women’s Health Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Women’s Health Diagnostics Revenue Market Share by Application (2021-2026) Table 37. Global Women’s Health Diagnostics Revenue Market Share by Application (2027-2032) Table 38. Siemens Company Information Table 39. Siemens Business Overview Table 40. Siemens Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Siemens Women’s Health Diagnostics Product Portfolio Table 42. Siemens Recent Development Table 43. Roche Company Information Table 44. Roche Business Overview Table 45. Roche Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Roche Women’s Health Diagnostics Product Portfolio Table 47. Roche Recent Development Table 48. Philips Company Information Table 49. Philips Business Overview Table 50. Philips Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Philips Women’s Health Diagnostics Product Portfolio Table 52. Philips Recent Development Table 53. Quest Diagnostics Inc. Company Information Table 54. Quest Diagnostics Inc. Business Overview Table 55. Quest Diagnostics Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio Table 57. Quest Diagnostics Inc. Recent Development Table 58. Perkinelmer Inc. Company Information Table 59. Perkinelmer Inc. Business Overview Table 60. Perkinelmer Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio Table 62. Perkinelmer Inc. Recent Development Table 63. Hologic, Inc. Company Information Table 64. Hologic, Inc. Business Overview Table 65. Hologic, Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Hologic, Inc. Women’s Health Diagnostics Product Portfolio Table 67. Hologic, Inc. Recent Development Table 68. GE Healthcare Company Information Table 69. GE Healthcare Business Overview Table 70. GE Healthcare Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GE Healthcare Women’s Health Diagnostics Product Portfolio Table 72. GE Healthcare Recent Development Table 73. Biomerieux SA Company Information Table 74. Biomerieux SA Business Overview Table 75. Biomerieux SA Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Biomerieux SA Women’s Health Diagnostics Product Portfolio Table 77. Biomerieux SA Recent Development Table 78. Becton, Dickinson and Company Company Information Table 79. Becton, Dickinson and Company Business Overview Table 80. Becton, Dickinson and Company Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio Table 82. Becton, Dickinson and Company Recent Development Table 83. Alere Inc. Company Information Table 84. Alere Inc. Business Overview Table 85. Alere Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Alere Inc. Women’s Health Diagnostics Product Portfolio Table 87. Alere Inc. Recent Development Table 88. Abbott Laboratories Company Information Table 89. Abbott Laboratories Business Overview Table 90. Abbott Laboratories Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Abbott Laboratories Women’s Health Diagnostics Product Portfolio Table 92. Abbott Laboratories Recent Development Table 93. North America Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 94. North America Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 95. North America Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 96. North America Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 97. North America Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Women’s Health Diagnostics Market Size by Country (2021-2026) Table 99. North America Women’s Health Diagnostics Market Size by Country (2027-2032) Table 100. Europe Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 101. Europe Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 102. Europe Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 103. Europe Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 104. Europe Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Women’s Health Diagnostics Market Size by Country (2021-2026) Table 106. Europe Women’s Health Diagnostics Market Size by Country (2027-2032) Table 107. China Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 108. China Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 109. China Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 110. China Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 111. Asia Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 112. Asia Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 113. Asia Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 114. Asia Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Women’s Health Diagnostics Market Size by Country (2021-2026) Table 117. Asia Women’s Health Diagnostics Market Size by Country (2027-2032) Table 118. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 119. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 120. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 121. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 122. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021-2026) Table 124. South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Women’s Health Diagnostics Product Image Figure 2. Global Women’s Health Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Women’s Health Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Diagnostic Devices Image Figure 5. Diagnostic Tests Image Figure 6. Global Women’s Health Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Women’s Health Diagnostics Market Share by Application: 2025 VS 2032 Figure 8. Infectious Disease Testing Image Figure 9. Osteoporosis Testing Image Figure 10. Pregnancy and Fertility Testing Image Figure 11. Breast Cancer Image Figure 12. Sexually Transmitted Disease Testing Image Figure 13. Others Image Figure 14. Global Women’s Health Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 16. Global Women’s Health Diagnostics Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Women’s Health Diagnostics Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Women’s Health Diagnostics Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Women’s Health Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Women’s Health Diagnostics Revenue Market Share by Type (2021-2032) Figure 23. Global Women’s Health Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Women’s Health Diagnostics Revenue Market Share by Application (2021-2032) Figure 25. North America Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 26. North America Women’s Health Diagnostics Market Share by Type (2021-2032) Figure 27. North America Women’s Health Diagnostics Market Share by Application (2021-2032) Figure 28. North America Women’s Health Diagnostics Market Share by Country (2021-2032) Figure 29. United States Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 30. Canada Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 33. Europe Women’s Health Diagnostics Market Share by Type (2021-2032) Figure 34. Europe Women’s Health Diagnostics Market Share by Application (2021-2032) Figure 35. Europe Women’s Health Diagnostics Market Share by Country (2021-2032) Figure 36. Germany Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 37. France Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 39. Italy Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. Russia Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 42. China Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 43. China Women’s Health Diagnostics Market Share by Type (2021-2032) Figure 44. China Women’s Health Diagnostics Market Share by Application (2021-2032) Figure 45. Asia Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 46. Asia Women’s Health Diagnostics Market Share by Type (2021-2032) Figure 47. Asia Women’s Health Diagnostics Market Share by Application (2021-2032) Figure 48. Asia Women’s Health Diagnostics Market Share by Country (2021-2032) Figure 49. Japan Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. India Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. Australia Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Women’s Health Diagnostics Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Women’s Health Diagnostics Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Women’s Health Diagnostics Market Share by Country (2021-2032) Figure 59. Brazil Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. UAE Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 66. Chile Women’s Health Diagnostics Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Devices
  • Diagnostic Tests
Applications
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Breast Cancer
  • Sexually Transmitted Disease Testing
  • Others
Companies covered
  • Siemens
  • Roche
  • Philips
  • Quest Diagnostics Inc.
  • Perkinelmer Inc.
  • Hologic, Inc.
  • GE Healthcare
  • Biomerieux SA
  • Becton, Dickinson and Company
  • Alere Inc.
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Women’s Health Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic Devices
  5. 1.2.3 Diagnostic Tests
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Women’s Health Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Infectious Disease Testing
  9. 1.3.3 Osteoporosis Testing
  10. 1.3.4 Pregnancy and Fertility Testing
  11. 1.3.5 Breast Cancer
  12. 1.3.6 Sexually Transmitted Disease Testing
  13. 1.3.7 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Women’s Health Diagnostics Growth Trends by Region
  16. 1.5.1 Global Women’s Health Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Women’s Health Diagnostics Market Size by Region (2021-2026)
  18. 1.5.3 Women’s Health Diagnostics Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Women’s Health Diagnostics Market Dynamics
  1. 2.1 Women’s Health Diagnostics Industry Trends
  2. 2.2 Women’s Health Diagnostics Industry Drivers
  3. 2.3 Women’s Health Diagnostics Industry Opportunities and Challenges
  4. 2.4 Women’s Health Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Women’s Health Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global Women’s Health Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Women’s Health Diagnostics Key Company Head office and Area Served
  4. 3.4 Global Women’s Health Diagnostics Company, Product Type & Application
  5. 3.5 Global Women’s Health Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Women’s Health Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Women’s Health Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Women’s Health Diagnostics Tier 1, Tier 2, and Tier 3
4 Women’s Health Diagnostics Market by Type
  1. 4.1 Global Women’s Health Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Women’s Health Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global Women’s Health Diagnostics Market Size Share by Type (2021-2032)
5 Women’s Health Diagnostics Market by Application
  1. 5.1 Global Women’s Health Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Women’s Health Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global Women’s Health Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Siemens
  2. 6.1.1 Siemens Company Information
  3. 6.1.2 Siemens Business Overview
  4. 6.1.3 Siemens Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Siemens Women’s Health Diagnostics Product Portfolio
  6. 6.1.5 Siemens Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Women’s Health Diagnostics Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Philips
  14. 6.3.1 Philips Company Information
  15. 6.3.2 Philips Business Overview
  16. 6.3.3 Philips Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Philips Women’s Health Diagnostics Product Portfolio
  18. 6.3.5 Philips Recent Developments
  19. 6.4 Quest Diagnostics Inc.
  20. 6.4.1 Quest Diagnostics Inc. Company Information
  21. 6.4.2 Quest Diagnostics Inc. Business Overview
  22. 6.4.3 Quest Diagnostics Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio
  24. 6.4.5 Quest Diagnostics Inc. Recent Developments
  25. 6.5 Perkinelmer Inc.
  26. 6.5.1 Perkinelmer Inc. Company Information
  27. 6.5.2 Perkinelmer Inc. Business Overview
  28. 6.5.3 Perkinelmer Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio
  30. 6.5.5 Perkinelmer Inc. Recent Developments
  31. 6.6 Hologic, Inc.
  32. 6.6.1 Hologic, Inc. Company Information
  33. 6.6.2 Hologic, Inc. Business Overview
  34. 6.6.3 Hologic, Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Hologic, Inc. Women’s Health Diagnostics Product Portfolio
  36. 6.6.5 Hologic, Inc. Recent Developments
  37. 6.7 GE Healthcare
  38. 6.7.1 GE Healthcare Company Information
  39. 6.7.2 GE Healthcare Business Overview
  40. 6.7.3 GE Healthcare Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GE Healthcare Women’s Health Diagnostics Product Portfolio
  42. 6.7.5 GE Healthcare Recent Developments
  43. 6.8 Biomerieux SA
  44. 6.8.1 Biomerieux SA Company Information
  45. 6.8.2 Biomerieux SA Business Overview
  46. 6.8.3 Biomerieux SA Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Biomerieux SA Women’s Health Diagnostics Product Portfolio
  48. 6.8.5 Biomerieux SA Recent Developments
  49. 6.9 Becton, Dickinson and Company
  50. 6.9.1 Becton, Dickinson and Company Company Information
  51. 6.9.2 Becton, Dickinson and Company Business Overview
  52. 6.9.3 Becton, Dickinson and Company Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio
  54. 6.9.5 Becton, Dickinson and Company Recent Developments
  55. 6.10 Alere Inc.
  56. 6.10.1 Alere Inc. Company Information
  57. 6.10.2 Alere Inc. Business Overview
  58. 6.10.3 Alere Inc. Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Alere Inc. Women’s Health Diagnostics Product Portfolio
  60. 6.10.5 Alere Inc. Recent Developments
  61. 6.11 Abbott Laboratories
  62. 6.11.1 Abbott Laboratories Company Information
  63. 6.11.2 Abbott Laboratories Business Overview
  64. 6.11.3 Abbott Laboratories Women’s Health Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Abbott Laboratories Women’s Health Diagnostics Product Portfolio
  66. 6.11.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Women’s Health Diagnostics Market Size (2021-2032)
  2. 7.2 North America Women’s Health Diagnostics Market Size by Type
  3. 7.2.1 North America Women’s Health Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America Women’s Health Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America Women’s Health Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America Women’s Health Diagnostics Market Size by Application
  7. 7.3.1 North America Women’s Health Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America Women’s Health Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America Women’s Health Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America Women’s Health Diagnostics Market Size by Country
  11. 7.4.1 North America Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Women’s Health Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America Women’s Health Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America Women’s Health Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Women’s Health Diagnostics Market Size (2021-2032)
  2. 8.2 Europe Women’s Health Diagnostics Market Size by Type
  3. 8.2.1 Europe Women’s Health Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Women’s Health Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Women’s Health Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe Women’s Health Diagnostics Market Size by Application
  7. 8.3.1 Europe Women’s Health Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Women’s Health Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Women’s Health Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe Women’s Health Diagnostics Market Size by Country
  11. 8.4.1 Europe Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Women’s Health Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Women’s Health Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Women’s Health Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Women’s Health Diagnostics Market Size (2021-2032)
  2. 9.2 China Women’s Health Diagnostics Market Size by Type
  3. 9.2.1 China Women’s Health Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China Women’s Health Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China Women’s Health Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China Women’s Health Diagnostics Market Size by Application
  7. 9.3.1 China Women’s Health Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China Women’s Health Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China Women’s Health Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Women’s Health Diagnostics Market Size (2021-2032)
  2. 10.2 Asia Women’s Health Diagnostics Market Size by Type
  3. 10.2.1 Asia Women’s Health Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Women’s Health Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Women’s Health Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia Women’s Health Diagnostics Market Size by Application
  7. 10.3.1 Asia Women’s Health Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Women’s Health Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Women’s Health Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia Women’s Health Diagnostics Market Size by Country
  11. 10.4.1 Asia Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Women’s Health Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Women’s Health Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Women’s Health Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Women’s Health Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Women’s Health Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Women’s Health Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Women’s Health Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Women’s Health Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst